10x Genomics, Inc. SEC filings TXG

10x Genomics, Inc. has 696 filings in SEC EDGAR's recent list, going back to May 9, 2019. Its latest annual report, Form 10-K, was filed on Feb 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

10x Genomics, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 4, 2026
DEFA14A Additional proxy material Apr 15, 2025 —
DEF 14A Proxy statement Apr 14, 2025 Jun 3, 2025
DEFA14A Additional proxy material Jun 6, 2024 —
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Jun 11, 2024
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 15, 2022
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 11, 2021
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Jun 15, 2020

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
TXG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Pleasanton, CA
SEC filer status
Large accelerated filer
SEC CIK
1770787

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.